A comprehensive evaluation of cardiac amyloidosis epidemiology and diagnostics in French Guiana
This study provides the first information on the diagnostic pathway for cardiac amyloidosis in French Guiana. The increasing proportion of undiagnosed patients has led us to create a French Guianese Amyloidosis Team to simplify the diagnostic pathway by focusing on cardiac MRI and biopsy, which can be performed locally. This is particularly important, as current and future therapeutic advances mean that more effective treatments are on the horizon.
Authors
- Karen Franck (ORCID: https://orcid.org/0000-0001-5372-3075)
- Cyrille Mathien (ORCID: https://orcid.org/0000-0001-7942-9448)
- Narcisse Elenga (ORCID: https://orcid.org/0000-0003-0624-4180)
- Grace-A-Dieu Yabeta
- Jeffrey D. Alexis (ORCID: https://orcid.org/0000-0002-1599-0487)
- Nathalie Deschamps (ORCID: https://orcid.org/0000-0001-6202-5762)
- Benoit Desjardins (ORCID: https://orcid.org/0000-0003-0693-4982)
- Inamo Jocelyn
- Thibaud Damy
- Franck Boteko
Institutions
- University of French Guiana (GF)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Centre Hospitalier Andrée Rosemon (GF)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Centre Hospitalier Universitaire de Martinique (MQ)
- Université Gustave Eiffel (FR)
- University of Guyana (GY)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1371/journal.pone.0324955
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00